drugset / Trial / NCT07089875
A Study of Dotinurad Versus Allopurinol in Participants With Gout
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with hyperuricemia associated with gout.
Timeline
- Start
- 2025-08-01
- Primary completion
- 2027-11-29
- Completion
- 2027-11-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Allopurinol | Small molecule | — | Oral |
| Subject | Dotinurad | Small molecule | 2 mg | Oral |
| Subject | Dotinurad | Small molecule | 4 mg | Oral |